Top officials at the event in Abu Dhabi.
Novartis is buying dry-eye medicine brand ‘Xiidra’ from Takeda Pharmaceutical for up to $5.3 billion as the Swiss pharma-maker refreshes its ophthalmic medicines portfolio with a potential blockbuster. The deal calls for $3.4 billion up front and milestone payments up to $1.9 billion, Novartis said.
The Department of Health-Abu Dhabi decided to withdraw 20 batches medical products used in catheterisation and other healthcare operations from the Emirate because of their possibility of causing serious infection to patients if they were not immediately substituted with good ones.
The first ever Network of Students in Medicine and Health (NeSMAH) conference shed light on some of the opportunities, challenges, and innovative strategies around the future of the healthcare sector in the UAE.
Recent initiatives in Gulf countries to facilitate patient access to new medicines and the advantages of integrating regulations related to drug trials and registration region wide were discussed at the GCC Regulatory Affairs Pharma Summit 2020,
Dr Thani Bin Ahmed Al Zeyoudi, UAE Minister of State for Foreign Trade, and Yulia Svyrydenko, First Deputy Prime Minister of Ukraine - Minister of Economy of Ukraine, on Monday
The UAE, represented by the Ministry of Finance (MoF) as the issuer, in collaboration with the Central Bank of the UAE (CBUAE) as the issuing and paying agent, has announced the results
Mubadala Investment Company (Mubadala), the Abu Dhabi sovereign investor, on Monday announced the transition of Musabbeh Al Kaabi from his current role as Chief Executive Officer